Ursodeoxycholic acid switches oxaliplati
✍
Sung-Chul Lim; Jeong Eun Choi; Ho Sung Kang; Han SI
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
French
⚖ 641 KB
## Abstract Hepatocellular carcinoma (HCC) is resistant to chemotherapy. Recently, however, several oxaliplatin‐based combinatorial treatments have shown a promising anti‐tumor activity in patients with HCC. Presently, we demonstrate that oxaliplatin triggers necrosis more than apoptosis in HepG2,